| Bioactivity | Avasopasem manganese (GC4419; M-40419) is a potent superoxide dismutase mimetic that rapidly and specifically converts O2*- to hydrogen peroxide (H2O2), arresting the initiation of this cascade. Avasopasem manganese can be used for the research of severe oral mucositis (SOM) and cancer[1]. | ||||||||||||
| In Vivo | Avasopasem manganese is an agent intended to interrupt severe oral mucositis pathogenesis, to reduce the duration, incidence, and severity of radiation-induced oral mucositis[1]. | ||||||||||||
| Name | Avasopasem manganese | ||||||||||||
| CAS | 435327-40-5 | ||||||||||||
| Formula | C21H35Cl2MnN5 | ||||||||||||
| Molar Mass | 483.38 | ||||||||||||
| Appearance | Solid | ||||||||||||
| Transport | Room temperature in continental US; may vary elsewhere. | ||||||||||||
| Storage |
|
||||||||||||
| Reference | [1]. Anderson CM, et al. Phase IIb, Randomized, Double-Blind Trial of GC4419 Versus Placebo to Reduce Severe Oral Mucositis Due to Concurrent Radiotherapy and Cisplatin For Head and Neck Cancer [published correction appears in J Clin Oncol. 2020 Jan 20;38(3):288]. J Clin Oncol. 2019;37(34):3256-3265. |
Avasopasem manganese
CAS: 435327-40-5 F: C21H35Cl2MnN5 W: 483.38
Avasopasem manganese (GC4419; M-40419) is a potent superoxide dismutase mimetic that rapidly and specifically converts O
Data collection：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.